Key result
Heterozygous E248K mice recapitulate human MYBPC1-associated myopathy, driven by disordered sarcomeres that reduce force production.
Why the study?
Dominant missense pathogenic variants in MYBPC1 cause an early-onset myopathy with myogenic tremor, but the in vivo mechanistic etiologies remained to be interrogated.
The generation of a knock-in mouse model carrying the MYBPC1 E248K variant provides a relevant preclinical model that recapitulates human myopathy phenotypes and reveals underlying sarcomeric deficits.
Offers preclinical model for MYBPC1 myopathy research; leaves open human translation pending validation.
Myosin binding protein-C slow (sMyBP-C) comprises a subfamily of cytoskeletal proteins encoded by MYBPC1 that is expressed in skeletal muscles where it contributes to myosin thick filament stabilization and actomyosin cross-bridge regulation. Recently, our group described the causal association of dominant missense pathogenic variants in MYBPC1 with an early-onset myopathy characterized by generalized muscle weakness, hypotonia, dysmorphia, skeletal deformities, and myogenic tremor, occurring in the absence of neuropathy. To mechanistically interrogate the etiologies of this MYBPC1-associated myopathy in vivo, we generated a knock-in mouse model carrying the E248K pathogenic variant. Using a battery of phenotypic, behavioral, and physiological measurements spanning neonatal to young adult life, we found that heterozygous E248K mice faithfully recapitulated the onset and progression of generalized myopathy, tremor occurrence, and skeletal deformities seen in human carriers. Moreover, using a combination of biochemical, ultrastructural, and contractile assessments at the level of the tissue, cell, and myofilaments, we show that the loss-of-function phenotype observed in mutant muscles is primarily driven by disordered and misaligned sarcomeres containing fragmented and out-of-register internal membranes that result in reduced force production and tremor initiation. Collectively, our findings provide mechanistic insights underscoring the E248K-disease pathogenesis and offer a relevant preclinical model for therapeutic discovery.
No takes yet. Share an insight, caveat, or question.
Hauserman et al. (2021) studied MYBPC1-associated myopathy with myogenic tremor. E248K pathogenic variant was evaluated on Onset and progression of generalized myopathy, tremor occurrence, and skeletal deformities. Heterozygous E248K knock-in mice recapitulated human MYBPC1-associated myopathy, driven by disordered sarcomeres that result in reduced force production and tremor initiation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: